AWHONN's Statement on Mifepristone Court Decision
April 14, 2023
April 14, 2023
WASHINGTON, April 14 (TNSgov) -- The Association of Women's Health, Obstetrics and Neonatal Nurses issued the following news release:
Two recent federal court decisions have resulted in contradictory rulings impacting the availability of mifepristone nationwide. Mifepristone is a drug used in medical abortion procedures and in managing miscarriages.
On April 7, 2023, Amarillo Division of the United States District Court for the Northern District of Texas Judge Matthew J . . .
Two recent federal court decisions have resulted in contradictory rulings impacting the availability of mifepristone nationwide. Mifepristone is a drug used in medical abortion procedures and in managing miscarriages.
On April 7, 2023, Amarillo Division of the United States District Court for the Northern District of Texas Judge Matthew J . . .